HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Cancer Research
Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention
Molecular Cancer Therapeutics
Molecular Cancer Research
Cancer Prevention Research
Cancer Prevention Journals Portal
Cancer Reviews Online
Annual Meeting Education Book
Meeting Abstracts Online
Cancer Research
67, , , . doi:
© 2009
American Association for Cancer Research
This Article
Abstract
Full Text
Services
Email this article to a friend
Alert me to new issues of the journal
PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with
EGFR
and
ERBB2
Mutations that Are Resistant to Gefitinib
Cancer Res Engelman et al. 67: 11924
Supplementary Data, Engelman, et al.
Files in this Data Supplement:
Supplementary Table 1
This Article
Abstract
Full Text
Services
Email this article to a friend
Alert me to new issues of the journal
HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Cancer Research
Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention
Molecular Cancer Therapeutics
Molecular Cancer Research
Cancer Prevention Research
Cancer Prevention Journals Portal
Cancer Reviews Online
Annual Meeting Education Book
Meeting Abstracts Online